Search - tctmd.com

Displaying 141 - 160 of 344

Sort: Relevancy | Date

News Opinion Editor's Corner ESC 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Shelley Wood

August 19, 2021

News Daily News

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Yael L. Maxwell

July 16, 2021

News Conference News EAS 2021

Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI

Michael O'Riordan

June 07, 2021

News Conference News EAS 2021

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

Michael O'Riordan

June 03, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2021

Shelley Wood

May 31, 2021

News Conference News ACC 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

L.A. McKeown

May 21, 2021

News Conference News ACC 2021

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

L.A. McKeown

May 16, 2021

News Conference News ACC 2021

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

Yael L. Maxwell

May 15, 2021

News Conference News SCAI 2021

Chinese Registry Supports Prolonged DAPT Following PCI for ACS

Yael L. Maxwell

May 03, 2021

News Daily News

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

Yael L. Maxwell

April 29, 2021

News Daily News

Lean Antithrombotic Regimen Recommended After TAVI

Todd Neale

April 12, 2021

News Daily News

Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All

L.A. McKeown

April 05, 2021

News Daily News

Meta-analysis Supports Genotype-Guided P2Y12 Prescription for ACS

Yael L. Maxwell

March 25, 2021

News Daily News

COVID-19: TCTMD’s Daily Dispatch for March Week 2

Todd Neale

March 08, 2021

News Daily News

Site Investigators Missed Clinical Events in GLOBAL LEADERS

Michael O'Riordan

February 12, 2021

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

News Conference News AHA 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Shelley Wood

November 15, 2020

News Daily News

FDA Grants Stroke Prevention Indication to Ticagrelor

Shelley Wood

November 06, 2020

News Daily News

Superiority of Ticagrelor Over Clopidogrel in ACS Questioned

Todd Neale

October 29, 2020

Advertisement

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

TCTMD’s Top 10 Most Popular Stories for May 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

Chinese Registry Supports Prolonged DAPT Following PCI for ACS

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

Lean Antithrombotic Regimen Recommended After TAVI

Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All

Meta-analysis Supports Genotype-Guided P2Y12 Prescription for ACS

COVID-19: TCTMD’s Daily Dispatch for March Week 2

Site Investigators Missed Clinical Events in GLOBAL LEADERS

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

FDA Grants Stroke Prevention Indication to Ticagrelor

Superiority of Ticagrelor Over Clopidogrel in ACS Questioned

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content